FTO and nasopharyngeal carcinoma: We can conclude that in NPC, ARHGAP35 can act codownstream of both FTO and ALKBH5 and promote the proliferation and migration of NPC cells through the FTO/ALKBH5-ARHGAP35 axis (Fig. 8).